Legal Representation
Attorney
Eric J Maiers
USPTO Deadlines
Next Deadline
522 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20210615)
Due Date
June 15, 2027
Grace Period Ends
December 15, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
40 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Dec 8, 2023 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB | Loading... |
| Nov 10, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED | Loading... |
| Oct 29, 2021 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB | Loading... |
| Sep 30, 2021 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB | Loading... |
| Sep 30, 2021 | FIMP | P | FINAL DISPOSITION PROCESSED | Loading... |
| Sep 15, 2021 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | Loading... |
| Jun 15, 2021 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Jun 13, 2021 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | Loading... |
| May 26, 2021 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| May 26, 2021 | OPNR | P | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | Loading... |
| Mar 30, 2021 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Mar 30, 2021 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Mar 28, 2021 | GPNX | P | NOTIFICATION PROCESSED BY IB | Loading... |
| Mar 10, 2021 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | Loading... |
| Mar 10, 2021 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | Loading... |
| Mar 10, 2021 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Feb 24, 2021 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Feb 24, 2021 | XAEC | I | EXAMINER'S AMENDMENT ENTERED | Loading... |
| Feb 24, 2021 | GNEN | O | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 24, 2021 | GNEA | O | EXAMINERS AMENDMENT E-MAILED | Loading... |
| Feb 24, 2021 | CNEA | R | EXAMINERS AMENDMENT -WRITTEN | Loading... |
| Feb 4, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 3, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 3, 2021 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Aug 4, 2020 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Aug 4, 2020 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Aug 4, 2020 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| May 19, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 18, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 18, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Feb 22, 2020 | RFNT | P | REFUSAL PROCESSED BY IB | Loading... |
| Feb 6, 2020 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | Loading... |
| Feb 6, 2020 | RFRR | P | REFUSAL PROCESSED BY MPU | Loading... |
| Jan 14, 2020 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | Loading... |
| Jan 13, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Jan 10, 2020 | MAFR | O | APPLICATION FILING RECEIPT MAILED | Loading... |
| Jan 6, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 6, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Dec 31, 2019 | LIMI | I | LIMITATION FROM ORIGINAL APPLICATION ENTERED | Loading... |
| Dec 26, 2019 | REPR | M | SN ASSIGNED FOR SECT 66A APPL FROM IB | Loading... |
Detailed Classifications
Class 001
Chemical reagents other than for medical or veterinary purposes; biological reagents other than for medical or veterinary purposes; biochemical catalysts; DNA encoded chemical compound for use in biochemical research; DNA encoded chemical preparations for use in biochemical research; intermediate of DNA encoded chemical compound for use in biochemical research; headpiece of DNA encoded chemical compound for use in biochemical research
First Use Anywhere:
0
First Use in Commerce:
0
Class 005
Medicines for human purpose, namely, drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals; chemical preparations for medical purpose for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease and ophthalmic diseases; chemical preparations for pharmaceutical purpose for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease and ophthalmic diseases; chemico-pharmaceutical preparations for treatment of cancer, inflammation, immune diseases, cardiovascular disease, metabolic disease and ophthalmic diseases
First Use Anywhere:
0
First Use in Commerce:
0
Class 035
Shop window dressing; outdoor advertising; bill-posting; distribution of samples; publicity services
First Use Anywhere:
0
First Use in Commerce:
0
Class 042
Technical project studies, namely, technical research in the field of pharmaceutical studies; chemical research services; chemical research; biological research; research services relating to DNA encoded library synthesis, namely, DNA analysis services for scientific research purposes; research services relating to DNA encoded library selection, namely, DNA screening for scientific research purposes; research services relating to DNA encoded library data analysis, namely, DNA screening for forensic research purposes
First Use Anywhere:
0
First Use in Commerce:
0
Additional Information
Design Mark
The mark consists of four stylized Chinese characters.
Color Claim
Color is not claimed as a feature of the mark.
Other
The non-Latin characters in the mark transliterate to "Xian Dao Yao Wu" and this means "the starting point of drug" in English.
Classification
International Classes
001
005
035
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
THE NON-LATIN CHARACTERS THAT TRANSLITERATE TO "YAO WU"